Cancer Research Institute

Cancer Research Institute CRI welcomes your comments and community participation, but reminds you to be careful about posting sensitive information about yourself or others.
(1303)

The Cancer Research Institute (CRI) is a nonprofit organization dedicated to advancing the field of cancer immunotherapy through rigorous scientific research and global collaboration. CRI is not responsible for the use, reproduction, or distribution of publicly posted information, and by posting such information you hereby indemnify and release CRI from any liability arising from such disclosure.

Cancer immunotherapy is transforming what’s possible for patients.The 2026 CRI Cancer Immunotherapy Insights + Impact Re...
06/01/2026

Cancer immunotherapy is transforming what’s possible for patients.

The 2026 CRI Cancer Immunotherapy Insights + Impact Report explores the latest breakthroughs, emerging treatments, and the momentum shaping the future of cancer care.

Read the report and discover the latest advancements in cancer immunotherapy: https://bit.ly/4eg8HTa

What cancers can be treated with immunotherapy? Learn how different types of immunotherapies work, get answers to your m...
05/31/2026

What cancers can be treated with immunotherapy? Learn how different types of immunotherapies work, get answers to your most frequently asked questions, and discover how immunotherapy is helping patients with different cancers: https://bit.ly/3YKAtxQ

Explore different kinds of treatment for various cancers, why immunotherapy matters, and how to support cancer immunotherapy research.

Being diagnosed with melanoma can feel overwhelming, and understanding your treatment options can make a meaningful diff...
05/30/2026

Being diagnosed with melanoma can feel overwhelming, and understanding your treatment options can make a meaningful difference.

↪️ Review 10 questions you may want to ask your health care team, in A Patient’s Guide to Cancer Immunotherapy: Melanoma:

A Patient's Guide to Cancer Immunotherapy Melanoma What You Need to Know Hearing the words “You have melanoma” can feel overwhelming. You may feel scared, confused, or uncertain about what comes next. [...]

05/29/2026

📆 June 1 marks the beginning of Cancer Immunotherapy Month, a celebration of the breakthroughs, hope, and progress transforming cancer treatment for patients everywhere!

Join CRI on social media all month long as we spotlight the power of immunotherapy and the people driving the field forward.

"Already, NIH spending on new medical research has slowed significantly," describes Jenney, a stage four melanoma surviv...
05/28/2026

"Already, NIH spending on new medical research has slowed significantly," describes Jenney, a stage four melanoma survivor.

"Nongovernmental and philanthropic organizations are helping. For example, the nonprofit Cancer Research Institute — for which I am a volunteer patient advocate — has funded immunotherapy research since its founding more than 70 years ago. Its work includes research that established the critical immune checkpoint targeted by my drug, and it has committed emergency reserve funding to keep research going. But private giving cannot replicate the scale of what federal investment makes possible." Read more: https://bit.ly/4f9crXI

Jenney Bitner: I'm not a scientist or policy expert. But I know that the drug that kept me alive for my children was built on a foundation of public investment.

At just 22 years old, Sharon was fighting a stage 4 melanoma diagnosis. Taking a leap of faith, she stepped into the unk...
05/27/2026

At just 22 years old, Sharon was fighting a stage 4 melanoma diagnosis. Taking a leap of faith, she stepped into the unknown of a clinical trial- an early immunotherapy, unproven but full of possibility.

Then, something remarkable happened. The cancer disappeared, and a future that had felt out of reach began to return, piece by fragile piece.

Decades later, that same science reached Jenney. Discover: https://bit.ly/4nOJQci

"I literally feel like I pitched them to get into the trial. My pitch was, I’m coming to you pretty much in great health...
05/26/2026

"I literally feel like I pitched them to get into the trial. My pitch was, I’m coming to you pretty much in great health, except for this cancer that will likely kill me," describes Adrienne, a stage 4 ampullary cancer survivor.

↘️ Hear how this sales exec talked her way into the clinical trial that saved her life:

After a stage 4 ampullary cancer diagnosis, Adrienne Skinner found hope through immunotherapy and a clinical trial that saved her life.

05/24/2026

Sharon was just 22 years old when she was diagnosed with stage 4 melanoma.

↪️ Discover how immunotherapy saved her life, during May's Melanoma Awareness Month: https://bit.ly/48TZe1p

Which immunotherapy drugs are used for melanoma today? Does immunotherapy work for everyone with melanoma? Discover the ...
05/23/2026

Which immunotherapy drugs are used for melanoma today? Does immunotherapy work for everyone with melanoma? Discover the answers to your most frequently asked questions regarding immunotherapy and melanoma, during May's Melanoma Awareness Month: https://bit.ly/4sWswTK

A Patient's Guide to Cancer Immunotherapy Melanoma What You Need to Know Hearing the words “You have melanoma” can feel overwhelming. You may feel scared, confused, or uncertain about what comes next. [...]

🔬 What are immunotherapy clinical trials, and how do they help patients? Learn about clinical trials for cancer treatmen...
05/22/2026

🔬 What are immunotherapy clinical trials, and how do they help patients? Learn about clinical trials for cancer treatment, and get answers to your most frequently asked questions, on our website:

Cancer clinical trials are critical to bringing new treatments to more patients. See if immunotherapy clinical trials are right for you.

Address

29 Broadway, 4th Floor
New York, NY
10006

Alerts

Be the first to know and let us send you an email when Cancer Research Institute posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share